Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development (including related party amounts of $226, $45, $442 and $90, respectively)	$ 11,295	$ 5,027	$ 20,054	$ 8,902
General and administrative (including related party amounts of $129, $60, $254 and $120, respectively)	4,344	2,660	8,955	4,465
Total operating expenses	15,639	7,687	29,009	13,367
Loss from operations	(15,639)	(7,687)	(29,009)	(13,367)
Other income, net	640	51	745	217
Net loss	$ (14,999)	$ (7,636)	$ (28,264)	$ (13,150)
Net loss per share, basic	$ (0.27)	$ (0.14)	$ (0.51)	$ (0.36)
Net loss per share, diluted	$ (0.27)	$ (0.14)	$ (0.51)	$ (0.36)
Weighted-average shares of common stock outstanding, basic	55,670,780	55,081,397	55,589,510	36,459,244
Weighted-average shares of common stock outstanding, diluted	55,670,780	55,081,397	55,589,510	36,459,244